Company intelligence / Profile preview

Prescript Pharmaceuticals

Ownership: Private
Development stage: Other

Overview

Prescript Pharmaceuticals was a pharmaceutical company that focused on the development of therapeutic agents for the treatment of cancer and infectious diseases. The company's research efforts were primarily directed toward the discovery and optimization of small molecule drugs. Despite its initial focus on high-need therapeutic areas, the company is no longer active in the biotechnology or pharmaceutical sectors. Information regarding its specific pipeline candidates and clinical progress remains limited due to its inactive status.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Prescript Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prescript Pharmaceuticals.

Explore the full profile